Dexamethasone use could reduce immune checkpoint inhibitor viability in glioblastoma patients Kumar Jeetendra | November 25, 2020 Bottom Line: One of patients with glioblastoma getting an immune checkpoint inhibitor, people who obtained the corticosteroid dexamethasone at baseline for cerebral edema had significantly worse overall survival. Journal Where the Study was Released: Clinical Cancer Research, a journal of the American Association for Cancer Research Author: David A. Reardon, MD, clinical director of the …
Eppendorf Award for Young European Investigators 2025 goes to Varun Venkataramani, Germany Kumar Jeetendra | July 9, 2025 This year, the Hamburg based life sciences company Eppendorf SE is awarding its prestigious research prize for the 30th time. The independent jury chaired by Prof. Laura Machesky, Cambridge, UK, selected Dr. Varun Venkataramani, Heidelberg University Hospital, Germany as the winner of the Eppendorf Award for Young European Investigators 2025. Varun Venkataramani receives the 20,000 …
